Increased ezrin expression and activation by CDK5 coincident with acquisition of the senescent phenotype

Molecular Cell

Volumn 11, Issue 5, 2003, Pages 1163-1176

  Yang, Hai Su ^a   Hinds, Philip W ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN BINDING PROTEIN; ANTIGEN; CDK5 ANTIGEN; EZRIN; UNCLASSIFIED DRUG;

ARTICLE; CELL MEMBRANE; CELL SHAPE; CONTROLLED STUDY; CYTOSKELETON; HUMAN; HUMAN CELL; PHENOTYPE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SENESCENCE; SIGNAL TRANSDUCTION;

EID: 0038392934     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1097-2765(03)00135-7     Document Type: Article

References (47)

1. Alexander K., Hinds P.W. Requirement for p27(KIP1) in retinoblastoma protein-mediated senescence. Mol. Cell. Biol. 21:2001;3616-3631.
2. Bretscher A. Regulation of cortical structure by the ezrin-radixin-moesin protein family. Curr. Opin. Cell Biol. 11:1999;109-116.
3. Bretscher A., Reczek D., Berryman M. Ezrin. a protein requiring conformational activation to link microfilaments to the plasma membrane in the assembly of cell surface structures J. Cell Sci. 110:1997;3011-3018.
4. Brookes S., Rowe J., Ruas M., Llanos S., Clark P.A., Lomax M., James M.C., Vatcheva R., Bates S., Vousden K.H.et al. INK4a-deficient human diploid fibroblasts are resistant to RAS-induced senescence. EMBO J. 21:2002;2936-2945.
5. Button E., Shapland C., Lawson D. Actin, its associated proteins and metastasis. Cell Motil. Cytoskeleton. 30:1995;247-251.
6. Campisi J. Replicative senescence. an old lives' tale? Cell. 84:1996;497-500.
7. Dai C.Y., Enders G.H. p16 INK4a can initiate an autonomous senescence program. Oncogene. 19:2000;1613-1622.
8. Dimri G.P., Lee X., Basile G., Acosta M., Scott G., Roskelley C., Medrano E.E., Linskens M., Rubelj I., Pereira-Smith O.et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl. Acad. Sci. USA. 92:1995;9363-9367.
9. Futreal P.A., Barrett J.C. Failure of senescent cells to phosphorylate the RB protein. Oncogene. 6:1991;1109-1113.
10. Gary R., Bretscher A. Ezrin self-association involves binding of an N-terminal domain to a normally masked C-terminal domain that includes the F-actin binding site. Mol. Biol. Cell. 6:1995;1061-1075.
11. Gautreau A., Louvard D., Arpin M. Morphogenic effects of ezrin require a phosphorylation-induced transition from oligomers to monomers at the plasma membrane. J. Cell Biol. 150:2000;193-203.
12. Gautreau A., Louvard D., Arpin M. ERM proteins and NF2 tumor suppressor. the Yin and Yang of cortical actin organization and cell growth signaling Curr. Opin. Cell Biol. 14:2002;104-109.
13. Goldstein S. Replicative senescence. the human fibroblast comes of age Science. 249:1990;1129-1133.
14. Goodrich D.W., Wang N.P., Qian Y.W., Lee E.Y., Lee W.H. The retinoblastoma gene product regulates progression through the G1 phase of the cell cycle. Cell. 67:1991;293-302.
15. Gumbiner B.M. Cell adhesion. the molecular basis of tissue architecture and morphogenesis Cell. 84:1996;345-357.
16. Gusella J.F., Ramesh V., MacCollin M., Jacoby L.B. Merlin. the neurofibromatosis 2 tumor suppressor Biochim. Biophys. Acta. 1423:1999;M29-M36.
17. Hinds P.W., Mittnacht S., Dulic V., Arnold A., Reed S.I., Weinberg R.A. Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell. 70:1992;993-1006.
18. Humbert S., Dhavan R., Tsai L. p39 activates cdk5 in neurons, and is associated with the actin cytoskeleton. J. Cell Sci. 113:2000;975-983.
19. Kiyono T., Foster S.A., Koop J.I., McDougall J.K., Galloway D.A., Klingelhutz A.J. Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells. Nature. 396:1998;84-88.
20. Kondo T., Takeuchi K., Doi Y., Yonemura S., Nagata S., Tsukita S. ERM (ezrin/radixin/moesin)-based molecular mechanism of microvillar breakdown at an early stage of apoptosis. J. Cell Biol. 139:1997;749-758.
21. Lamb R.F., Ozanne B.W., Roy C., McGarry L., Stipp C., Mangeat P., Jay D.G. Essential functions of ezrin in maintenance of cell shape and lamellipodial extension in normal and transformed fibroblasts. Curr. Biol. 7:1997;682-688.
22. Louvet-Vallee S. ERM proteins. from cellular architecture to cell signaling Biol. Cell. 92:2000;305-316.
23. Lundberg A.S., Hahn W.C., Gupta P., Weinberg R.A. Genes involved in senescence and immortalization. Curr. Opin. Cell Biol. 12:2000;705-709.
24. Magendantz M., Henry M.D., Lander A., Solomon F. Interdomain interactions of radixin in vitro. J. Biol. Chem. 270:1995;25324-25327.
25. Matsui T., Maeda M., Doi Y., Yonemura S., Amano M., Kaibuchi K., Tsukita S. Rho-kinase phosphorylates COOH-terminal threonines of ezrin/radixin/moesin (ERM) proteins and regulates their head-to-tail association. J. Cell Biol. 140:1998;647-657.
26. Nikolic M., Chou M.M., Lu W., Mayer B.J., Tsai L.H. The p35/Cdk5 kinase is a neuron-specific Rac effector that inhibits Pak1 activity. Nature. 395:1998;194-198.
27. Otto J.J. Vinculin. Cell Motil. Cytoskeleton. 16:1990;1-6.
28. Pearson M.A., Reczek D., Bretscher A., Karplus P.A. Structure of the ERM protein moesin reveals the FERM domain fold masked by an extended actin binding tail domain. Cell. 101:2000;259-270.
29. Qin X.Q., Chittenden T., Livingston D.M., Kaelin W.G. Jr. Identification of a growth suppression domain within the retinoblastoma gene product. Genes Dev. 6:1992;953-964.
30. Rheinwald J.G., Hahn W.C., Ramsey M.R., Wu J.Y., Guo Z., Tsao H., De Luca M., Catricala C., O'Toole K.M. A two-stage, p16(INK4A)- and p53-dependent keratinocyte senescence mechanism that limits replicative potential independent of telomere status. Mol. Cell. Biol. 22:2002;5157-5172.
31. Schmitt C.A., Fridman J.S., Yang M., Lee S., Baranov E., Hoffman R.M., Lowe S.W. A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy. Cell. 109:2002;335-346.
32. Sedivy J.M. Can ends justify the means? telomeres and the mechanisms of replicative senescence and immortalization in mammalian cells Proc. Natl. Acad. Sci. USA. 95:1998;9078-9081.
33. Sellers W.R., Rodgers J.W., Kaelin W.G. Jr. A potent transrepression domain in the retinoblastoma protein induces a cell cycle arrest when bound to E2F sites. Proc. Natl. Acad. Sci. USA. 92:1995;11544-11548.
34. Simons P.C., Pietromonaco S.F., Reczek D., Bretscher A., Elias L. C-terminal threonine phosphorylation activates ERM proteins to link the cell's cortical lipid bilayer to the cytoskeleton. Biochem. Biophys. Res. Commun. 253:1998;561-565.
35. Smith J.R., Pereira-Smith O.M. Replicative senescence. implications for in vivo aging and tumor suppression Science. 273:1996;63-67.
36. Stein G.H., Beeson M., Gordon L. Failure to phosphorylate the retinoblastoma gene product in senescent human fibroblasts. Science. 249:1990;666-669.
37. Sui G., Soohoo C., Affar el B., Gay F., Shi Y., Forrester W.C. A DNA vector-based RNAi technology to suppress gene expression in mammalian cells. Proc. Natl. Acad. Sci. USA. 99:2002;5515-5520.
38. Takahashi K., Sasaki T., Mammoto A., Takaishi K., Kameyama T., Tsukita S., Takai Y. Direct interaction of the Rho GDP dissociation inhibitor with ezrin/radixin/moesin initiates the activation of the Rho small G protein. J. Biol. Chem. 272:1997;23371-23375.
39. Takahashi K., Sasaki T., Mammoto A., Hotta I., Takaishi K., Imamura H., Nakano K., Kodama A., Takai Y. Interaction of radixin with Rho small G protein GDP/GTP exchange protein Dbl. Oncogene. 16:1998;3279-3284.
40. Tarricone C., Dhavan R., Peng J., Areces L.B., Tsai L.H., Musacchio A. Structure and regulation of the CDK5-p25(nck5a) complex. Mol. Cell. 8:2001;657-669.
41. Templeton D.J., Park S.H., Lanier L., Weinberg R.A. Nonfunctional mutants of the retinoblastoma protein are characterized by defects in phosphorylation, viral oncoprotein association, and nuclear tethering. Proc. Natl. Acad. Sci. USA. 88:1991;3033-3037.
42. Tiemann F., Hinds P.W. Induction of DNA synthesis and apoptosis by regulated inactivation of a temperature-sensitive retinoblastoma protein. EMBO J. 17:1998;1040-1052.
43. Vidal A., Millard S.S., Miller J.P., Koff A. Rho activity can alter the translation of p27 mRNA and is important for RasV12-induced transformation in a manner dependent on p27 status. J. Biol. Chem. 277:2002;16433-16440.
44. Weinberg R.A. The retinoblastoma protein and cell cycle control. Cell. 81:1995;323-330.
45. Xu H.J., Zhou Y., Ji W., Perng G.S., Kruzelock R., Kong C.T., Bast R.C., Mills G.B., Li J., Hu S.X. Reexpression of the retinoblastoma protein in tumor cells induces senescence and telomerase inhibition. Oncogene. 15:1997;2589-2596.
46. Yonemura S., Hirao M., Doi Y., Takahashi N., Kondo T., Tsukita S. Ezrin/radixin/moesin (ERM) proteins bind to a positively charged amino acid cluster in the juxta-membrane cytoplasmic domain of CD44, CD43, and ICAM-2. J. Cell Biol. 140:1998;885-895.
47. Zigmond S.H. Signal transduction and actin filament organization. Curr. Opin. Cell Biol. 8:1996;66-73.